EUVIMEDEUVIMED entdecken
Open Access

Systemic Administration of Lipopolysaccharide from Porphyromonas gingivalis Decreases Neprilysin Expression in the Mouse Hippocampus

Tetsuro Morikawa, Osamu Uehara, Durga Paudel, Koki Yoshida, Fumiya Harada, Daichi Hiraki, Jun Sato, Hirofumi Matsuoka, Yasuhiro Kuramitsu, Makoto Michikawa, Yoshihiro Abiko

In Vivo · 2023

DOI: 10.21873/invivo.13065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2023. Verfasst von Tetsuro Morikawa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oral Medicine and Pathology, Department of Human Biology and Pathophysiology, School of Dentistry, Health Sciences University of Hokkaido…. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Alzheimer's disease is the most common type of neurodegenerative disorder in elderly individuals worldwide. Increasing evidence suggests that periodontal diseases are involved in the pathogenesis of Alzheimer's disease, and an association between periodontitis and amyloid-β deposition in elderly individuals has been demonstrated. The aim of the present study was to examine the effects of systemic administration of Porphyromonas gingivalis-derived lipopolysaccharide (PG-LPS) on neprilysin expression in the hippocampus of adult and senescence-accelerated mice. MATERIALS AND METHODS: PG-LPS diluted in saline was intraperitoneally administered to male C57BL/6J and senescence-accelerated mouse prone 8 (SAMP8) mice at a dose of 5 mg/kg every 3 days for 3 months. Both C57BL/6J and SAMP8 mice administered saline without PG-LPS comprised the control group. The mRNA expression levels of neprilysin and interleukin (IL)-10 were evaluated using the quantitative reverse transcriptase-polymerase chain reaction. The protein levels of neprilysin were assessed using western blotting. Sections of the brain tissues were immunohistochemically stained. RESULTS: The serum IL-10 concentration significantly increased in both mouse strains after stimulation with PG-LPS. Neprilysin expression at both mRNA and protein levels was significantly lower in the SAMP8 PG-LPS group than those in the SAMP8 control group; however, they did not differ in PG-LPS-treated or non-treated C57BL/6J mice. Additionally, the immunofluorescence intensity of neprilysin in the CA3 region of the hippocampus in PG-LPS-treated SAMP8 mice was significantly lower than that in control SAMP8 mice. CONCLUSION: Porphyromonas gingivalis may reduce the expression of neprilysin in elderly individuals and thus increase amyloid-β deposition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMaleMiceAnimalsLipopolysaccharidesPorphyromonas gingivalisNeprilysinMice, Inbred C57BLAmyloid beta-PeptidesHippocampusRNA, Messenger

Stichwörter der Autor:innen

Alzheimer’s DiseasePorphyromonas gingivalishippocampusneprilysinperiodontitis

Substanzen

LipopolysaccharidesNeprilysinAmyloid beta-PeptidesRNA, Messenger

Autor:innen und Institutionen

  • Division of Oral Medicine and Pathology, Department of Human Biology and Pathophysiology, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.
  • Division of Disease Control and Molecular Epidemiology, Department of Oral Growth and Development, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.
  • Advanced Research Promotion Center, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.
  • Division of Oral and Maxillofacial Surgery, Department of Human Biology and Pathophysiology, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.
  • Division of Reconstructive Surgery for Oral and Maxillofacial Region, Department of Human Biology and Pathophysiology, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.
  • Department of Biochemistry, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.

Zitieren

APA

Morikawa, T., Uehara, O., Paudel, D., Yoshida, K., Harada, F., Hiraki, D., Sato, J., Matsuoka, H., Kuramitsu, Y., Michikawa, M., & Abiko, Y. (2023). Systemic Administration of Lipopolysaccharide from Porphyromonas gingivalis Decreases Neprilysin Expression in the Mouse Hippocampus. In Vivo. https://doi.org/10.21873/invivo.13065

Vancouver

Morikawa T, Uehara O, Paudel D, Yoshida K, Harada F, Hiraki D, et al. Systemic Administration of Lipopolysaccharide from Porphyromonas gingivalis Decreases Neprilysin Expression in the Mouse Hippocampus. In Vivo. 2023. doi:10.21873/invivo.13065

BibTeX
@article{Morikawa2023,
  author = {Morikawa, Tetsuro and Uehara, Osamu and Paudel, Durga and Yoshida, Koki and Harada, Fumiya and Hiraki, Daichi and Sato, Jun and Matsuoka, Hirofumi and Kuramitsu, Yasuhiro and Michikawa, Makoto and Abiko, Yoshihiro},
  title = {Systemic Administration of Lipopolysaccharide from Porphyromonas gingivalis Decreases Neprilysin Expression in the Mouse Hippocampus},
  journal = {In Vivo},
  year = {2023},
  doi = {10.21873/invivo.13065}
}
Kostenlos starten →